| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 4. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | ursodeoxycholic acid (Ursofalk®) |
| Formulation | 500 mg film-coated tablet |
| Reference number | 1973 |
| Indication | Treatment of primary biliary cirrhosis, provided there is no decompensated hepatic cirrhosis, and for the dissolution of cholesterol gallstones in the gall bladder. The gallstones must not show as shadows on X-ray images and should not exceed 15 mm in diameter |
| Company | Dr Falk Pharma UK Ltd |
| BNF chapter | Gastro-intestinal system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 06/04/2013 |